Clinical Trial

Phase 3 to Evaluate the Efficacy and Safety of DWP14012 in Patients With Gastric Ulcer

Name: Phase 3 to Evaluate the Efficacy and Safety of DWP14012 in Patients With Gastric Ulcer — clinical trial record (NCT07730138)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

A Multinational, Multicenter, Randomized, Double-blind, Active-controlled, Parallel-group, Phase 3 Study to Evaluate the Efficacy and Safety of DWP14012 in Participants with Gastric Ulcer

Trial Details

NCT Number	NCT07730138
Lead Sponsor	Daewoong Pharmaceutical Co. LTD.
Conditions	Gastric Ulcer
Enrollment	384 participants
Start Date	2026-10-15
Primary Completion	2028-04-15 (estimated)
Study Completion	2028-10-15 (estimated)
Updated on ClinicalTrials.gov	2026-07-28